Title
|
|
|
|
Management of neuropathic pain after surgical and non-surgical trauma with lidocaine 5% patches: study of 40 consecutive cases
| |
Author
|
|
|
|
| |
Abstract
|
|
|
|
Objective: To determine the efficacy of lidocaine 5% patches* *Versatis, commercialised by Grünenthal GmbH, Aachen, Germany. in patients with PNCCP. Background: This study focuses on chronic pain states of a neuropathic nature, located at the scar or over a larger area of the skin around the scar. This post-operative/post-traumatic neuropathic chronic cutaneous pain (PNCCP) may be a side-effect of any incision of the skin in the context of a surgical procedure or a traumatic event. Research design and methods: A single-centre, open, non-randomised, prospective study was performed in a university hospital referral centre for patients with chronic neuropathic pain after surgical or non-surgical trauma. Forty consecutive patients with chronic PNCCP, a VAS score ≥5, a LANSS score ≥12, and a stable consumption of pain medication were prospectively evaluated. All patients were given lidocaine 5% patches, following a 12h on/off schedule. Main outcome measures: Visual analogue scale (VAS) and the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) scorings were performed pretreatment (day 0), on the 28th day (4weeks), and after 84days (12weeks). |
| |
Language
|
|
|
|
English
| |
Source (journal)
|
|
|
|
Current medical research and opinion. - London
| |
Publication
|
|
|
|
London
:
2009
| |
ISSN
|
|
|
|
0300-7995
| |
Volume/pages
|
|
|
|
25
:11
(2009)
, p. 2737-2743
| |
ISI
|
|
|
|
000273417700018
| |
Full text (Publisher's DOI)
|
|
|
|
| |
|